Hydration in hemolytic uremic syndrome. / Hidratación en el síndrome urémico hemolítico.
Arch Argent Pediatr
; 119(1): 62-66, 2021 02.
Article
em En, Es
| MEDLINE
| ID: mdl-33458983
ABSTRACT
Diarrhea-associated hemolytic uremic syndrome is preceded by gastroenteritis due to Shiga toxin-producing Escherichia coli. Support measures are recommended, specifically, fluid restriction to avoid cardiopulmonary overload. However, in the prodromal period or with established hemolytic uremic syndrome, volume expansion with isotonic fluids is safe and effective, and reduces the need for dialysis, the length of hospital and intensive care stay, neurological events, and hyponatremia. Therefore, when nephrological monitoring is available and/or short-term access to a tertiary care hospital is guaranteed, it is suggested to hydrate patients with no signs of cardiopulmonary overload, regardless of their renal function, with initial volume expansion. Afterwards, if an adequate urine output is achieved, the patient should not be dialyzed (except if they have a medically intractable metabolic/electrolyte disorder) and hydration should be continued with an isotonic solution containing 5 % dextrose for adequate hydration and urine output.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Escherichia coli Shiga Toxigênica
/
Gastroenterite
/
Síndrome Hemolítico-Urêmica
Tipo de estudo:
Diagnostic_studies
Limite:
Humans
Idioma:
En
/
Es
Revista:
Arch Argent Pediatr
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Argentina